Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan(®) and Mowel(®) after liver transplantation

BACKGROUND: Expensive pharmaceuticals are a major reason for cost intensive health care systems. Long-term immunosuppressive therapy plays a relevant role after organ transplantation. Patents of original drugs have expired and cheaper products are available. Little data are available regarding effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Vollmar, Johanna, Bellmann, Maren Christina, Darstein, Felix, Hoppe-Lotichius, Maria, Mittler, Jens, Heise, Michael, Rüttger, Bernd, Weyer, Veronika, Zimmermann, Anca, Lang, Hauke, Galle, Peter R, Zimmermann, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655904/
https://www.ncbi.nlm.nih.gov/pubmed/26604701
http://dx.doi.org/10.2147/DDDT.S92490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655904/
https://www.ncbi.nlm.nih.gov/pubmed/26604701
http://dx.doi.org/10.2147/DDDT.S92490

Ejemplares similares